FORMULATION AND EVALUATION OF IBUPROFEN CONTROLLED RELEASE MATRIX TABLETS USING ITS SOLID DISPERSION
Objective: The aim of the present work was to prepare solid dispersion of ibuprofen with PEG 6000 to increase the aqueous solubility of the drug and to develop the solid dispersed ibuprofen into tablet formulation with the combination of a hydrophilic and hydrophobic polymer to attain controlled release of ibuprofen.
Methods: Solid dispersion of ibuprofen was prepared by melting-solvent method by varying the ratio of drug and PEG 6000. The solid dispersed ibuprofen was subjected to tablet formulation by using a hydrophilic swellable polymer-carbopol and hydrophobic non-swellable polymer-ethyl cellulose. The release of the drug from the polymer matrix was studied as the polymer ratio changes.
Results: Compatibility between drug and polymers was established from FT-IR study. The saturated solubility was found to increase in the solid dispersed formulation. The swelling index was found within the range of 90±5.43 to 137±6.41. SEM image of swollen tablet confirmed the presence of irregular and porous surface. The cumulative drug release was found to vary within the range of 68.76±3.04 to 95.33±2.34 % after 8 h of dissolution.
Conclusion: The combination of solid dispersion and application of hydrophilic and hydrophobic polymers in matrix formation can facilitate better dissolution and absorption profile with greater patient compliance.
2. Sharma D, Soni M, Kumar S, Gupta GD. Solubility enhancement-eminent role in poorly soluble drugs. Res J Pharm Tech 2009;2:220-4.
3. Patidar K, Soni M, Sharma KD, Jain KS. Solid dispersion: approaches, technology involved, unmet need and challenges. Drug Invention Today 2010;2:349-57.
4. Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50:47-60.
5. Krishnaiah YSR. Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs. J Bioequiv Availab 2010;2:28-36.
6. Jain SK, Shukla M, Shrivastava V. Development and in vitro evaluation of ibuprofen mouth dissolving tablets using solid dispersion technique. Chem Pharm Bull 2010;58:1037-42.
7. Livshits A, Machtinger R, David LB, Spira M, Moshe Zahav A, Seidman DS. Ibuprofen and paracetamol for pain relief during a medical abortion: a double-blind randomized controlled study. Fertil Steril 2009;91:1877-80.
8. Laurel JMG, Benjamin DS. Cyclooxygenase-2 inhibitors: promise or peril? Mediators Inflamm 2002;11:275–86.
9. Akarca US. Gastrointestinal effects of selective and non-selective non-steroidal anti-inflammatory drugs. Curr Pharm Des 2005;11:1779-93.
10. Afshin Z, Sara A. Selective COX-2 inhibitors: a review of their structure-activity relationships. Iran J Pharm Res 2011;10:655–83.
11. Luong C, Miller A, Barnett J, Chow J, Ramesha C, Browner MF. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nat Struct Biol 1996;3:927–33.
12. Meek IL, Laar MAFJVD, Vonkeman HE. Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention. Semin Arthritis Rheum 2010;39:294–312.
13. Yanbin H, Wei-Guo D. Fundamental aspects of solid dispersion technology for poorly soluble drugs. Acta Pharm Sin B 2014;4:18–25.
14. Tsume Y, Amidon GL, Takeuchi S. Dissolution effect of gastric and intestinal PH for a BCS class II drug, pioglitazone: new in vitro dissolution system to predict in vivo dissolution. J Bioequiv Availab 2013;5:224-7.
15. Shobhit K, Satish KG. Pharmaceutical solid dispersion technology: a strategy to improve the dissolution of poorly water-soluble drugs. Recent Pat Drug Delivery Formul 2013;7:111-21.
16. Maulvi FA, Dalwadi SJ, Thakhar VT. Improvement of dissolution rate of aceclofenac by solid dispersion technique. Powder Technol 2011;207:47-54.
17. Waghmare A, Pore Y, Kuchekar B. Development and characterization of zaleplon solid dispersion systems: a technical note. AAPS PharmSciTech 2008;9:536-43.
18. Konno H, Handa T, Alonzo DE, Taylor LS. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine. Eur J Pharm Biopharm 2008;70:493-9.
19. Verheyen S, Blaton N, Kinget R, Mooter VDG. Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions. Int J Pharm 2002;249:45-58.
20. Manna S, Jayasri K, Annapurna KR, Kanthal LK. Alginate-based gastro-retentive raft-forming tablets for enhanced bioavailability of tinidazole. Int J Appl Pharm 2017;9:16-21.
21. Ladan AN, Gurinder S, Gaurav S, Kimia FK. Solid dispersion: methods and polymers to increase the solubility of poorly soluble drugs. J Appl Pharm Sci 2012;2:170-5.
22. Sweta KS, Vijay S, Kamla P. Formulation and evaluation of taste masked rapid release tablets of sumatriptan succinate. Int J Pharm Pharm Sci 2012;4:168-74.
23. Sharma A, Jain CP. Preparation and characterization of solid dispersions of carvedilol with PVP K30. Res Pharm Sci 2010;5:49–56.
24. Jian XW, Mingshi Y, Frans VDB, Jari P, Thomas R, Jukka R. Influence of solvent evaporation rate and formulation factors on solid dispersion physical stability. Eur J Pharm Sci 2011;44:610-20.
25. Ahad HA, Anand BU, Nagesh K, Sai KD, Bindu MK. Fabrication of glimepiride datura stramonium leaves mucilage and polyvinyl pyrrolidone sustained release matrix tablets: in vitro evaluation. Kathmandu Univ J Sci Eng Tech 2012;8:63-72.
26. Dattatraya MS, Pooja SA, Parag DK, Avish DM. Formulation and in vitro evaluation of fast dissolving tablet of verapamil hydrochloride. Int J Pharm Pharm Sci 2018;10:93-9.
27. Aulton ME. Pharmaceutics, the science of dosage form design. Oxford: Churchill Livingstone; 2005.
28. Poreddy SR, Penjuri SCB, Damineni S, Vuppula S. Formulation and evaluation of colon targeted matrix tablet using natural tree gums. Int J Pharm Pharm Sci 2018;10:92-7.
29. Masum MAA, Florida S, Islam SMA, Reza MS. Enhancement of solubility and dissolution characteristics of ibuprofen by solid dispersion technique. Dhaka Univ J Pharm Sci 2012;11:1-6.
30. Al-Taani BM, Tashtoush BM. Effect of microenvironment pH of swellable and erodable buffered matrices on the release characteristics of diclofenac sodium. AAPS PharmSciTech 2003;4:1-6.
31. Colombo P. Swelling-controlled release in hydrogel matrices for oralroute. Adv Drug Delivery Rev 1993;11:37-57.
32. Ganesh S, Radhakrishnan M, Ravi M, Prasannakumar B, Kalyani J. In vitro evaluation of the effect of the combination of hydrophilic and hydrophobic polymers on controlled release zidovudine matrix tablets. Indian J Pharm Sci 2008;70:461–5.
33. Bourne DWA. Pharmacokinetics. In: Banker GS, Rhodes CT. ed. Mordern Pharmaceutics. Marcel Dekker, New York; 2002.
34. Higuchi T. Mechanism of sustained action medication. Theoritical analysis of the rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963;52:1145-9.
35. Ritger PL, Peppas NA. A simple equation for description of solute release I. fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Controlled Release 1987;5:23-36.
36. Zahra S, Azade T, Alireza H. Preparation and physicochemical characterization of meloxicam orally fast disintegration tablet using its solid dispersion. Braz J Pharm Sci 2017;53:1-9.
37. Gupta MM, Patel MG, Patel NS, Madhulika K. Enhancement of dissolution rate of ibuprofen by preparing solid dispersion using different methods. Int J Pharm Pharm Sci 2011;3:204-6.
38. Hadi MA, Lokeswara BV, Pal N. Formulation and evaluation of sustained release matrix tablets of glimepiride based on the combination of hydrophilic and hydrophobic polymers. J Appl Pharm Sci 2012;2:101-7.